|
|
||||||||
|
FIGURE 2. Tumor dissemination in CMM involves both lymphatic and hematogenous pathways. During course of disease, any organ may be affected, including skin and subcutaneous, nodal, and visceral sites.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |